Global trends and future directions on carbapenem-resistant Enterobacteriaceae (CRE) research: A comprehensive bibliometric analysis (2020-2024). [PDF]
Gürbüz M, Gencer G.
europepmc +1 more source
Efficacy, Safety, and Cost-Effectiveness Analysis of Ceftazidime-Avibactam versus Polymyxin B in the Treatment of Carbapenem-Resistant Enterobacteriaceae Infections: A Target Trial Emulation. [PDF]
Hu N +12 more
europepmc +1 more source
Risk Factors Analysis and Prediction Model Establishment for Carbapenem-Resistant Enterobacteriaceae Colonization: A Retrospective Cohort Study. [PDF]
Guo X +9 more
europepmc +1 more source
Microbiome Therapeutic Lactiplantibacillus plantarum PMC105 for Systemic Carbapenem-Resistant Enterobacteriaceae Infections: Oral and Inhalation Efficacy In Vivo. [PDF]
Sarafraz F +6 more
europepmc +1 more source
Mortality-related risk factors of carbapenem-resistant Enterobacteriaceae infection with focus on antimicrobial regimens optimization: a real-world retrospective study in China. [PDF]
Deng S, Chen J, Zhou P, Hu Q.
europepmc +1 more source
Clinical outcomes and the impact of treatment modalities in children with carbapenem-resistant Enterobacteriaceae bloodstream infections: a retrospective cohort study from a tertiary university hospital. [PDF]
Avcu G +8 more
europepmc +1 more source
Carbapenem-resistant Enterobacteriaceae in the livestock, humans and environmental samples around the globe: a systematic review and meta-analysis. [PDF]
Tuhamize B, Bazira J.
europepmc +1 more source
Challenges of Carbapenem-Resistant <i>Enterobacteriaceae</i> in the Development of New β-Lactamase Inhibitors and Antibiotics. [PDF]
Leroux P, Bornet C, Bolla JM, Cohen A.
europepmc +1 more source

